Postlicensure safety evaluation of human papilloma virus vaccines

Jerry Labadie1

  • 1Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden. jerry.labadie@who-umc.org

Abstract